This is the authors' abstract. We don't add key points for this paper.
Central venous catheters are essential for treatment of cancer and hematologic disorders in children. Central line-associated bloodstream infection (CLABSI) is the most common important complication and can lead to serious sequelae. Conventional antibiotic treatment is often unsuccessful. Ethanol lock therapy (ELT) has been shown to prevent CLABSI in various patient groups and might also be beneficial as adjunctive treatment for active infection. Efficacy and safety have not been adequately studied in the pediatric hematology/oncology population. Catheter occlusion and intraluminal clots have been reported. Routine use of ELT should not be recommended in this population until more data are available.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: